Valuation: Acarix AB

Market Cap 304M 31.48M 27.57M 25.4M 23.57M 44.76M 3B 45.37M 118M 1.47B 118M 116M 5.11B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 304M 31.48M 27.57M 25.4M 23.57M 44.76M 3B 45.37M 118M 1.47B 118M 116M 5.11B EV / Sales 2026 *
15.9x
EV / Sales 2027 * 4.37x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-3.57%
1 week-3.46%
Current month-3.46%
1 month+3.33%
3 months-3.79%
6 months+3.72%
Current year-8.52%
1 week 0.03
Extreme 0.02785
0.03
1 month 0.03
Extreme 0.0275
0.03
Current year 0.02
Extreme 0.0234
0.04
1 year 0.02
Extreme 0.0234
0.04
3 years 0.01
Extreme 0.009
0.07
5 years 0.01
Extreme 0.009
0.07
10 years 0.01
Extreme 0.009
0.07
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Operating Officer 62 2009-11-30
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 50 2024-05-13
Director/Board Member - 2024-05-13
Director/Board Member 61 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.57%-3.46% - - 31.46M
+1.46%+2.68%+4.93%-25.89% 16.36B
-4.23%+13.31%+39.95%+97.00% 1.78B
-1.37%-1.26%-40.38%-78.19% 1.24B
-0.31%+3.80%-28.39%+37.99% 1.14B
0.00%+1.60%-25.50%-52.75% 640M
-2.22%-4.47%-38.00%-56.03% 582M
+1.23%+7.62%+22.05%-53.18% 447M
-0.32%+0.32%-55.36%-59.44% 382M
-2.05%+5.91%-22.07%-20.86% 362M
Average -1.14%+3.47%-15.86%-23.48% 2.55B
Weighted average by Cap. +0.55%+3.29%+0.51%-18.52%

Financials

2026 *2027 *
Net sales 19.1M 1.98M 1.73M 1.6M 1.48M 2.81M 189M 2.85M 7.43M 92.62M 7.43M 7.27M 321M 69.5M 7.2M 6.3M 5.81M 5.39M 10.23M 687M 10.37M 27.05M 337M 27.03M 26.44M 1.17B
Net income -28.9M -2.99M -2.62M -2.41M -2.24M -4.26M -285M -4.31M -11.25M -140M -11.24M -10.99M -486M 2.4M 249K 218K 200K 186K 353K 23.71M 358K 934K 11.64M 933K 913K 40.35M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
26-07-06 US$0.0279 -3.57% 10,000

Quarterly revenue - Rate of surprise